Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Goldenwell Biotech's shares outstanding was 99M at Jun 30, 2026. For fiscal 2025 it was 99M, up 0.0% from the year before. The highest annual figure on record is 99M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 99M | 0.0% |
| FY2024 | Dec 31, 2024 | 99M | 0.0% |
| FY2023 | Dec 31, 2023 | 99M | +8.4% |
| FY2021 | Dec 31, 2021 | 91M | +14.2% |
| FY2020 | Dec 31, 2020 | 80M | +5.0% |
| FY2019 | Dec 31, 2019 | 76M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 99M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 99M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | 99M | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | 96M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 99M | +2.7% |
| Q1 FY2025 | Mar 31, 2025 | 99M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | 99M | +2.7% |
| Q3 FY2024 | Sep 30, 2024 | 96M | +5.6% |
| Q2 FY2024 | Jun 30, 2024 | 96M | +5.6% |
| Q1 FY2024 | Mar 31, 2024 | 99M | +8.4% |
| Q2 FY2023 | Jun 30, 2023 | 96M | +5.6% |
| Q2 FY2022 | Jun 30, 2022 | 91M | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | 91M | +14.2% |
| Q3 FY2021 | Sep 30, 2021 | 91M | +14.2% |
| Q2 FY2021 | Jun 30, 2021 | 91M | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | 91M | +14.2% |
| Q4 FY2020 | Dec 31, 2020 | 80M | +184.5% |
| Q3 FY2020 | Sep 30, 2020 | 80M | – |
| Q2 FY2020 | Jun 30, 2020 | 80M | – |
| Q1 FY2020 | Mar 31, 2020 | 80M | – |
| Q3 FY2019 | Sep 30, 2019 | 28M | – |
See a number that looks wrong?